The purpose of this study is to assess acceptability, and safety of providing tDCS to ADRD patients with behavioral symptoms and to assess the efficacy of tDCS for ADRD-related symptoms, mainly behavioral symptoms.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Acceptability of the tDCS Treatment as Assessed by the tDCS Acceptability Questionnaire
Timeframe: week 2
Acceptability of the tDCS Treatment as Assessed by the tDCS Acceptability Questionnaire
Timeframe: week 4
Acceptability of the tDCS Treatment as Assessed by the tDCS Acceptability Questionnaire
Timeframe: week 6
Acceptability of the tDCS Treatment as Assessed by the tDCS Acceptability Questionnaire
Timeframe: week 12
Safety as Assessed by the Side Effects Questionnaire
Timeframe: week 2
Safety as Assessed by the Side Effects Questionnaire
Timeframe: week 4
Safety as Assessed by the Side Effects Questionnaire
Timeframe: week 6